Israel Practice Co-Chair Bob Grossman led a multi-office team of Greenberg Traurig attorneys who represented longtime client OPKO HEALTH, INC. (NYSE:OPK) in the negotiation of a definitive merger agreement with Bio-Reference Laboratories, Inc. (NASDAQ:BRLI). OPKO is also traded as one of the largest companies on the Tel Aviv Stock Exchange. The $1.47 billion transaction, announced June 4, is expected to be completed during the second half of 2015. OPKO is a multinational biopharmaceutical and diagnostics…